Status:
RECRUITING
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
Lead Sponsor:
Fondazione Italiana Linfomi - ETS
Collaborating Sponsors:
Takeda
Conditions:
Cutaneous T Cell Lymphoma
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Eligibility:
All Genders
18+ years
Brief Summary
The study is designed to describe the different approaches of systemic therapies for the treatment of Cutaneous T-cell Lymphoma in real world setting.
Detailed Description
The treatment of Mycosis Fungoides (MF)/Sézary Syndrome (SS) is based on a multimodal approach through the involvement of different specialists including hematologists, dermatologists, and radiation t...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of CTCL according to the EORTC 2017 update criteria1.
- Age ≥18 years.
- Have received first dose of a systemic therapy, lasted at least 3 months, between 1 January 2016 and 31 December 2023.
- Availability of complete medical records in order to provide protocol required variables
- Signed written informed consent.
Exclusion
- Patients not meeting the above-mentioned inclusion criteria.
- Refuse to sign a written informed consent.
Key Trial Info
Start Date :
February 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06588868
Start Date
February 27 2025
End Date
July 1 2026
Last Update
December 2 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Ospedali Riuniti delle Marche - Clinica di Ematologia
Ancona, Italy
2
IRCCS Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia
Bari, Italy
3
U.O.C. Dermatologia e Venereologia Universitaria - A.O.U. Policlinico Consorziale
Bari, Italy
4
Policlinico S.Orsola-Malpighi - Istituto di Ematologia
Bologna, Italy